Filing Details
- Accession Number:
- 0001321732-20-000171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-14 21:34:54
- Reporting Period:
- 2020-12-11
- Accepted Time:
- 2020-12-14 21:34:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1321732 | Penumbra Inc | PEN | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651323 | Adam Elsesser | One Penumbra Place Alameda CA 94502 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-11 | 500 | $186.87 | 965,082 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 400 | $188.20 | 964,682 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 1,000 | $189.06 | 963,682 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 2,728 | $189.86 | 960,954 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 600 | $190.94 | 960,354 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 972 | $191.94 | 959,382 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 1,000 | $193.02 | 958,382 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 400 | $193.83 | 957,982 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 300 | $194.85 | 957,682 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2020-12-11 | 100 | $197.24 | 957,582 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Footnotes
- The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $186.53 to $187.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- Shares are held by the Siegel/Elsesser Revocable Trust.
- This transaction was executed in multiple trades at prices ranging from $188.07 to $188.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $188.65 to $189.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $189.55 to $190.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $190.72 to $191.38. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $191.58 to $192.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $192.54 to $193.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $193.55 to $194.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $194.56 to $195.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
